Press Release | NeoGenomics Laboratories

December 30, 2015

NeoGenomics Completes Acquisition of Clarient, Inc.

December 8, 2015

NeoGenomics Launches New Liquid Biopsy Tests for Monitoring Solid Tumors and Predicting Resistance to BTK Inhibitors

October 29, 2015

NeoGenomics Reports Revenue of $25.1 Million and Record Adjusted EBITDA of $2.8 Million Driven by a 25% Increase in Test Volume in the Third Quarter of 2015

October 28, 2015

NeoGenomics Amends Strategic Alliance Agreement with Covance Central Laboratory Services

October 21, 2015

NeoGenomics Signs Definitive Agreement to Acquire Clarient, Inc.

October 12, 2015

NeoGenomics Schedules its Q3 2015 Earnings Release for October 29, 2015

September 23, 2015

NeoGenomics Launches New NeoSITE™ Cervical FISH Assay for Evaluation of Abnormal Pap Tests

September 2, 2015

NeoGenomics Enters into National Agreement with Premier, Inc. to Offer Cancer Genetics Testing Services to 3,600 Hospitals

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients